Cargando…
Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap
BACKGROUND: Current guidelines for acute coronary syndrome recommend clopidogrel for an optimal period of 12 months in order to reduce the risk of reinfarction and mortality. Premature clopidogrel discontinuation has been associated with higher rates of rehospitalization, coronary stent thrombosis,...
Autores principales: | Page, Robert Lee, Ghushchyan, Vahram, Allen, Richard R, Roper, Lisa, Beck, Don, Jonathan, Bamrom H, Frech-Tamas, Feride, Chan, Wing, McQueen, R Brett, Nair, Kavita V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402012/ https://www.ncbi.nlm.nih.gov/pubmed/22826644 http://dx.doi.org/10.2147/DHPS.S32473 |
Ejemplares similares
-
Incremental increases in economic burden parallels cardiometabolic risk factors in the US
por: McQueen, R Brett, et al.
Publicado: (2016) -
Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both
por: Ghushchyan, Vahram, et al.
Publicado: (2014) -
Utilization of Medicare services by beneficiaries having partial Medicare coverage
por: McCall, Nelda
Publicado: (1983) -
Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017
por: Bartlett, Victoria L., et al.
Publicado: (2020) -
Prescription Drug Coverage and Spending for Medicare Beneficiaries
por: Poisal, John A., et al.
Publicado: (1999)